| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.973 | 0.002 | 0.99 | 5 Hydroxytryptamine 1 agonist | 0.99 0.002 CID_10614907 0.872 0.003 CID_154699772 | CID_10614907 | |
| 0.936 | 0.001 | 0.936 | 5 Hydroxytryptamine 1B antagonist | 0.935 0.001 CID_10614907 0.611 0.003 CID_154699772 | ||
| 0.935 | 0.003 | 0.935 | 5 Hydroxytryptamine antagonist | 0.911 0.003 CID_10614907 0.721 0.004 CID_154699772 | ||
| 0.92 | 0.002 | 0.92 | 5 Hydroxytryptamine 1 antagonist | 0.902 0.002 CID_10614907 0.785 0.003 CID_154699772 | ||
| 0.888 | 0.003 | 0.956 | 5 Hydroxytryptamine agonist | 0.956 0.002 CID_10614907 0.757 0.004 CID_154699772 | CID_10614907 | |
| 0.874 | 0.001 | 0.899 | 5 Hydroxytryptamine 1D antagonist | 0.899 0.001 CID_10614907 0.454 0.003 CID_154699772 | CID_10614907 | |
| 0.819 | 0.001 | 0.819 | 5 Hydroxytryptamine 1D agonist | 0.757 0.001 CID_10614907 0.391 0.002 CID_154699772 | ||
| 0.816 | 0.002 | 0.893 | 5 Hydroxytryptamine 1B agonist | 0.893 0.001 CID_10614907 0.655 0.002 CID_154699772 | CID_10614907 | |
| 0.651 | 0.004 | 0.651 | 5 Hydroxytryptamine 2C antagonist | 0.53 0.004 CID_10614907 0.244 0.013 CID_154699772 | ||
| 0.639 | 0.004 | 0.639 | 5 Hydroxytryptamine 2 antagonist | 0.476 0.007 CID_10614907 0.315 0.015 CID_154699772 | ||
| 0.589 | 0.004 | 0.589 | 5 Hydroxytryptamine 2A antagonist | 0.438 0.006 CID_10614907 0.289 0.012 CID_154699772 | ||
| 0.535 | 0.004 | 0.535 | 5 Hydroxytryptamine 1A antagonist | 0.511 0.004 CID_10614907 0.369 0.007 CID_154699772 | ||
| 0.503 | 0.009 | 0.503 | Sigma receptor agonist | 0.434 0.017 CID_10614907 0.191 0.065 CID_154699772 | ||
| 0.518 | 0.024 | 0.625 | 5 Hydroxytryptamine release stimulant | 0.625 0.012 CID_10614907 0.312 0.066 CID_154699772 | CID_10614907 | |
| 0.457 | 0.006 | 0.457 | 5 Hydroxytryptamine 2B antagonist | 0.35 0.011 CID_10614907 0.186 0.029 CID_154699772 | ||
| 0.457 | 0.015 | 0.457 | Anticonvulsant | 0.288 0.044 CID_10614907 0.412 0.02 CID_154699772 | ||
| 0.386 | 0.005 | 0.502 | 5 Hydroxytryptamine 1A agonist | 0.502 0.004 CID_10614907 0.121 0.013 CID_154699772 | CID_10614907 | |
| 0.369 | 0.005 | 0.39 | 5 Hydroxytryptamine 1F antagonist | 0.39 0.005 CID_10614907 0.15 0.016 CID_154699772 | CID_10614907 | |
| 0.334 | 0.006 | 0.334 | Dopamine D4 antagonist | 0.129 0.02 CID_10614907 0.093 0.028 CID_154699772 | ||
| 0.354 | 0.037 | 0.354 | HERG channel blocker | 0.152 0.129 CID_10614907 0.245 0.068 CID_154699772 | ||
| 0.327 | 0.01 | 0.327 | Dopamine antagonist | 0.174 0.022 CID_10614907 0.109 0.035 CID_154699772 | ||
| 0.294 | 0.016 | 0.294 | Alpha adrenoreceptor antagonist | 0.247 0.02 CID_10614907 0.282 0.017 CID_154699772 | ||
| 0.286 | 0.008 | 0.286 | Alpha 1b adrenoreceptor antagonist | 0.203 0.014 CID_10614907 0.271 0.009 CID_154699772 | ||
| 0.323 | 0.049 | 0.357 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.357 0.033 CID_10614907 | CID_10614907 | |
| 0.276 | 0.007 | 0.323 | 5 Hydroxytryptamine uptake inhibitor | 0.323 0.005 CID_10614907 0.259 0.008 CID_154699772 | CID_10614907 | |
| 0.31 | 0.047 | 0.31 | Potassium channel (Voltage-sensitive) blocker | 0.222 0.082 CID_154699772 | ||
| 0.38 | 0.12 | 0.452 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.452 0.06 CID_10614907 0.289 0.228 CID_154699772 | CID_10614907 | |
| 0.268 | 0.01 | 0.32 | 5 Hydroxytryptamine 3E antagonist | 0.32 0.004 CID_10614907 0.199 0.064 CID_154699772 | CID_10614907 | |
| 0.259 | 0.009 | 0.26 | Alpha 2c adrenoreceptor antagonist | 0.26 0.009 CID_10614907 0.14 0.037 CID_154699772 | CID_10614907 | |
| 0.254 | 0.004 | 0.254 | 5 Hydroxytryptamine 5A antagonist | 0.166 0.006 CID_10614907 0.058 0.048 CID_154699772 | ||
| 0.259 | 0.012 | 0.259 | Dopamine D2 antagonist | 0.133 0.025 CID_10614907 0.07 0.044 CID_154699772 | ||
| 0.247 | 0.004 | 0.247 | Myeloperoxidase inhibitor | 0.157 0.01 CID_10614907 0.135 0.014 CID_154699772 | ||
| 0.249 | 0.008 | 0.293 | 5 Hydroxytryptamine 7 antagonist | 0.293 0.006 CID_10614907 0.059 0.046 CID_154699772 | CID_10614907 | |
| 0.255 | 0.014 | 0.255 | Alpha 1 adrenoreceptor antagonist | 0.19 0.022 CID_10614907 0.222 0.018 CID_154699772 | ||
| 0.25 | 0.014 | 0.296 | Alpha 2b adrenoreceptor antagonist | 0.296 0.009 CID_10614907 0.176 0.03 CID_154699772 | CID_10614907 | |
| 0.229 | 0.004 | 0.229 | 5 Hydroxytryptamine 5 antagonist | 0.151 0.007 CID_10614907 | ||
| 0.232 | 0.013 | 0.232 | Alpha 1a adrenoreceptor antagonist | 0.163 0.021 CID_10614907 0.164 0.021 CID_154699772 | ||
| 0.222 | 0.012 | 0.222 | Histamine H1 receptor antagonist | 0.15 0.024 CID_10614907 0.097 0.043 CID_154699772 | ||
| 0.213 | 0.008 | 0.213 | Multidrug resistance-associated protein 1 inhibitor | 0.094 0.09 CID_10614907 0.095 0.087 CID_154699772 | ||
| 0.263 | 0.061 | 0.299 | 5 Hydroxytryptamine 1E antagonist | 0.299 0.03 CID_10614907 | CID_10614907 | |
| 0.211 | 0.009 | 0.22 | Alpha 1d adrenoreceptor antagonist | 0.152 0.014 CID_10614907 0.22 0.008 CID_154699772 | CID_154699772 | |
| 0.205 | 0.02 | 0.205 | Antihistaminic | 0.2 0.021 CID_10614907 0.09 0.064 CID_154699772 | ||
| 0.203 | 0.019 | 0.203 | Histamine antagonist | 0.194 0.02 CID_10614907 0.08 0.064 CID_154699772 | ||
| 0.263 | 0.082 | 0.263 | Ca(v)3.3 blocker | 0.205 0.182 CID_10614907 | ||
| 0.194 | 0.021 | 0.194 | Nav1.6 sodium channel blocker | 0.153 0.051 CID_10614907 0.118 0.099 CID_154699772 | ||
| 0.238 | 0.066 | 0.238 | Interleukin antagonist | 0.219 0.075 CID_10614907 0.226 0.071 CID_154699772 | ||
| 0.188 | 0.021 | 0.189 | GABA receptor agonist | 0.189 0.02 CID_10614907 0.119 0.058 CID_154699772 | CID_10614907 | |
| 0.172 | 0.01 | 0.172 | Sigma receptor antagonist | 0.068 0.024 CID_10614907 0.105 0.015 CID_154699772 | ||
| 0.148 | 0.004 | 0.148 | 5 Hydroxytryptamine 7 agonist | 0.13 0.005 CID_10614907 0.052 0.047 CID_154699772 | ||
| 0.209 | 0.08 | 0.209 | ErbB-1 antagonist | 0.176 0.123 CID_10614907 0.171 0.131 CID_154699772 | ||
| 0.196 | 0.079 | 0.196 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.185 0.089 CID_10614907 | ||
| 0.145 | 0.029 | 0.201 | Alpha 2 adrenoreceptor antagonist | 0.201 0.018 CID_10614907 0.08 0.066 CID_154699772 | CID_10614907 | |
| 0.202 | 0.091 | 0.389 | Potassium channel blocker | 0.389 0.024 CID_154699772 | CID_154699772 | |
| 0.147 | 0.037 | 0.207 | Antiadrenergic | 0.178 0.029 CID_10614907 0.207 0.023 CID_154699772 | CID_154699772 | |
| 0.144 | 0.036 | 0.205 | Adrenaline antagonist | 0.176 0.028 CID_10614907 0.205 0.023 CID_154699772 | CID_154699772 | |
| 0.123 | 0.019 | 0.123 | Dopamine D3 antagonist | 0.09 0.028 CID_10614907 | ||
| 0.107 | 0.004 | 0.107 | Dopamine beta hydroxylase inhibitor | 0.061 0.014 CID_10614907 0.056 0.021 CID_154699772 | ||
| 0.175 | 0.075 | 0.175 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.157 0.084 CID_10614907 | ||
| 0.14 | 0.041 | 0.241 | 5 Hydroxytryptamine 3A agonist | 0.241 0.006 CID_10614907 | CID_10614907 | |
| 0.186 | 0.088 | 0.21 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.21 0.065 CID_10614907 0.165 0.112 CID_154699772 | CID_10614907 | |
| 0.171 | 0.073 | 0.171 | Antipruritic | 0.128 0.127 CID_10614907 | ||
| 0.178 | 0.082 | 0.178 | P-glycoprotein inhibitor | |||
| 0.119 | 0.024 | 0.12 | GABA A receptor agonist | 0.12 0.024 CID_10614907 | CID_10614907 | |
| 0.104 | 0.016 | 0.186 | Alpha 1 adrenoreceptor agonist | 0.144 0.01 CID_10614907 0.186 0.007 CID_154699772 | CID_154699772 | |
| 0.149 | 0.062 | 0.213 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.213 0.038 CID_10614907 | CID_10614907 | |
| 0.143 | 0.066 | 0.198 | Neurotrophic factor | 0.115 0.104 CID_10614907 0.198 0.028 CID_154699772 | CID_154699772 | |
| 0.113 | 0.038 | 0.138 | Lanosterol 14 alpha demethylase inhibitor | 0.089 0.075 CID_10614907 0.138 0.017 CID_154699772 | CID_154699772 | |
| 0.092 | 0.018 | 0.097 | 5 Hydroxytryptamine 2A agonist | 0.097 0.016 CID_10614907 | CID_10614907 | |
| 0.109 | 0.035 | 0.122 | Alpha 2d adrenoreceptor antagonist | 0.122 0.022 CID_10614907 0.094 0.061 CID_154699772 | CID_10614907 | |
| 0.098 | 0.024 | 0.1 | CC chemokine 5 receptor agonist | 0.1 0.021 CID_10614907 | CID_10614907 | |
| 0.081 | 0.008 | 0.137 | Somatostatin 4 agonist | 0.137 0.005 CID_10614907 0.062 0.011 CID_154699772 | CID_10614907 | |
| 0.103 | 0.03 | 0.268 | NMDA 2 receptor antagonist | 0.068 0.053 CID_10614907 0.268 0.005 CID_154699772 | CID_154699772 | |
| 0.137 | 0.065 | 0.277 | Toll-Like receptor antagonist | 0.277 0.009 CID_10614907 | CID_10614907 | |
| 0.092 | 0.021 | 0.127 | 5 Hydroxytryptamine 3A antagonist | 0.127 0.008 CID_10614907 | CID_10614907 | |
| 0.09 | 0.02 | 0.09 | Acetylcholine M5 receptor antagonist | 0.066 0.034 CID_10614907 0.078 0.025 CID_154699772 | ||
| 0.097 | 0.028 | 0.136 | Dopamine agonist | 0.136 0.017 CID_10614907 0.067 0.046 CID_154699772 | CID_10614907 | |
| 0.109 | 0.042 | 0.293 | NMDA receptor antagonist | 0.087 0.058 CID_10614907 0.293 0.007 CID_154699772 | CID_154699772 | |
| 0.094 | 0.028 | 0.107 | Viral attachment inhibitor | 0.107 0.019 CID_10614907 | CID_10614907 | |
| 0.095 | 0.031 | 0.113 | Polo-like kinase-2 inhibitor | 0.113 0.015 CID_10614907 0.064 0.06 CID_154699772 | CID_10614907 | |
| 0.205 | 0.142 | 0.281 | Gastrin inhibitor | 0.281 0.047 CID_10614907 | CID_10614907 | |
| 0.093 | 0.031 | 0.171 | Alpha adrenoreceptor agonist | 0.17 0.013 CID_10614907 0.171 0.012 CID_154699772 | CID_154699772 | |
| 0.257 | 0.197 | 0.468 | Calcium channel L-type activator | 0.305 0.153 CID_10614907 0.468 0.041 CID_154699772 | CID_154699772 | |
| 0.103 | 0.043 | 0.196 | Histamine N-methyltransferase inhibitor | 0.196 0.005 CID_10614907 | CID_10614907 | |
| 0.068 | 0.008 | 0.068 | Sigma 1 receptor antagonist | 0.028 0.018 CID_10614907 0.051 0.01 CID_154699772 | ||
| 0.095 | 0.039 | 0.168 | Alpha 2a adrenoreceptor antagonist | 0.168 0.019 CID_10614907 | CID_10614907 | |
| 0.205 | 0.152 | 0.251 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.251 0.064 CID_10614907 | CID_10614907 | |
| 0.078 | 0.026 | 0.104 | Dopamine uptake inhibitor | 0.05 0.049 CID_10614907 0.104 0.017 CID_154699772 | CID_154699772 | |
| 0.059 | 0.008 | 0.059 | Sigma 2 receptor antagonist | 0.05 0.01 CID_154699772 | ||
| 0.127 | 0.079 | 0.174 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.174 0.054 CID_10614907 | CID_10614907 | |
| 0.107 | 0.062 | 0.129 | Mediator release inhibitor | 0.129 0.04 CID_10614907 0.121 0.047 CID_154699772 | CID_10614907 | |
| 0.065 | 0.022 | 0.065 | Neurokinin antagonist | 0.056 0.028 CID_10614907 0.046 0.041 CID_154699772 | ||
| 0.071 | 0.029 | 0.088 | 5 Hydroxytryptamine 6 antagonist | 0.088 0.019 CID_10614907 | CID_10614907 | |
| 0.065 | 0.023 | 0.109 | Histamine agonist | 0.109 0.008 CID_10614907 | CID_10614907 | |
| 0.043 | 0.004 | 0.053 | Factor IX inhibitor | 0.052 0.004 CID_10614907 0.053 0.004 CID_154699772 | CID_154699772 | |
| 0.113 | 0.077 | 0.254 | M18 aspartyl aminopeptidase inhibitor | 0.149 0.053 CID_10614907 0.254 0.02 CID_154699772 | CID_154699772 | |
| 0.068 | 0.031 | 0.09 | Cyclin D1 inhibitor | 0.09 0.012 CID_10614907 | CID_10614907 | |
| 0.059 | 0.022 | 0.071 | Histamine H3 receptor antagonist | 0.071 0.019 CID_10614907 | CID_10614907 | |
| 0.151 | 0.115 | 0.373 | Psychostimulant | 0.373 0.027 CID_10614907 | CID_10614907 | |
| 0.068 | 0.033 | 0.089 | Bombesin 1 receptor agonist | 0.089 0.021 CID_10614907 0.053 0.051 CID_154699772 | CID_10614907 | |
| 0.094 | 0.059 | 0.097 | Alcohol dehydrogenase inhibitor | 0.097 0.056 CID_10614907 | CID_10614907 | |
| 0.049 | 0.017 | 0.085 | Kainate receptor 2 antagonist | 0.085 0.006 CID_10614907 | CID_10614907 | |
| 0.195 | 0.164 | 0.195 | Nootropic | 0.193 0.168 CID_154699772 | ||
| 0.144 | 0.115 | 0.15 | Lipocortins synthesis antagonist | 0.149 0.107 CID_10614907 0.15 0.105 CID_154699772 | CID_154699772 | |
| 0.16 | 0.134 | 0.16 | Antiamyloidogenic | 0.154 0.143 CID_154699772 | ||
| 0.037 | 0.01 | 0.061 | Kainate receptor 4 antagonist | 0.061 0.005 CID_10614907 0.03 0.014 CID_154699772 | CID_10614907 | |
| 0.078 | 0.052 | 0.103 | Nicotinic alpha4beta2 receptor antagonist | 0.103 0.028 CID_10614907 | CID_10614907 | |
| 0.146 | 0.121 | 0.29 | DNA methylase inhibitor | 0.29 0.031 CID_10614907 | CID_10614907 | |
| 0.229 | 0.204 | 0.229 | Analgesic | |||
| 0.055 | 0.031 | 0.097 | Factor IXa inhibitor | 0.065 0.023 CID_10614907 0.097 0.01 CID_154699772 | CID_154699772 | |
| 0.049 | 0.026 | 0.049 | Dopamine D5 antagonist | 0.044 0.029 CID_10614907 0.04 0.032 CID_154699772 | ||
| 0.053 | 0.03 | 0.06 | Bombesin 2 receptor antagonist | 0.06 0.024 CID_10614907 | CID_10614907 | |
| 0.044 | 0.022 | 0.045 | Substance P antagonist | 0.045 0.021 CID_10614907 0.038 0.028 CID_154699772 | CID_10614907 | |
| 0.045 | 0.023 | 0.073 | Dopamine D3 agonist | 0.073 0.01 CID_10614907 | CID_10614907 | |
| 0.07 | 0.048 | 0.11 | Protein kinase B alpha inhibitor | 0.11 0.024 CID_10614907 | CID_10614907 | |
| 0.054 | 0.033 | 0.072 | 5 Hydroxytryptamine 2 agonist | 0.072 0.018 CID_10614907 | CID_10614907 | |
| 0.053 | 0.032 | 0.053 | Dopamine D4 agonist | 0.052 0.033 CID_10614907 | ||
| 0.045 | 0.025 | 0.045 | Neurokinin 2 antagonist | |||
| 0.055 | 0.036 | 0.209 | NMDA 2B receptor antagonist | 0.209 0.005 CID_154699772 | CID_154699772 | |
| 0.045 | 0.026 | 0.051 | GHS receptor agonist | 0.051 0.019 CID_10614907 | CID_10614907 | |
| 0.049 | 0.031 | 0.055 | Bombesin antagonist | 0.055 0.023 CID_10614907 | CID_10614907 | |
| 0.063 | 0.046 | 0.063 | Dopamine D1 antagonist | 0.062 0.048 CID_10614907 | ||
| 0.041 | 0.024 | 0.041 | Melanocortin 1 antagonist | 0.04 0.025 CID_10614907 | ||
| 0.153 | 0.14 | 0.167 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.167 0.122 CID_10614907 | CID_10614907 | |
| 0.104 | 0.091 | 0.178 | Glutamate receptor antagonist | 0.178 0.034 CID_154699772 | CID_154699772 | |
| 0.033 | 0.02 | 0.048 | Somatostatin agonist | 0.048 0.014 CID_10614907 0.032 0.021 CID_154699772 | CID_10614907 | |
| 0.038 | 0.026 | 0.048 | Cholecystokinin A antagonist | 0.048 0.02 CID_10614907 | CID_10614907 | |
| 0.06 | 0.049 | 0.079 | Histone deacetylase SIRT3 inhibitor | 0.079 0.019 CID_10614907 | CID_10614907 | |
| 0.04 | 0.03 | 0.057 | Cholecystokinin antagonist | 0.057 0.021 CID_10614907 | CID_10614907 | |
| 0.129 | 0.12 | 0.172 | CF transmembrane conductance regulator agonist | 0.172 0.045 CID_10614907 | CID_10614907 | |
| 0.108 | 0.099 | 0.108 | Nav1.2 sodium channel blocker | |||
| 0.083 | 0.075 | 0.083 | Breast cancer-resistant protein inhibitor | |||
| 0.036 | 0.027 | 0.045 | Bombesin 1 receptor antagonist | 0.045 0.017 CID_10614907 | CID_10614907 | |
| 0.037 | 0.029 | 0.054 | Somatostatin 1 antagonist | 0.045 0.023 CID_10614907 0.054 0.018 CID_154699772 | CID_154699772 | |
| 0.111 | 0.103 | 0.111 | Interleukin 1 antagonist | |||
| 0.061 | 0.054 | 0.137 | Toll-Like receptor 7 antagonist | 0.137 0.008 CID_10614907 | CID_10614907 | |
| 0.017 | 0.012 | 0.025 | Kainate receptor 3 antagonist | 0.025 0.007 CID_10614907 | CID_10614907 | |
| 0.043 | 0.038 | 0.045 | Melanocortin antagonist | 0.045 0.035 CID_10614907 | CID_10614907 | |
| 0.015 | 0.013 | 0.015 | Cholecystokinin A agonist | 0.014 0.013 CID_10614907 | ||
| 0.031 | 0.03 | 0.038 | Somatostatin 5 agonist | 0.038 0.02 CID_10614907 0.031 0.029 CID_154699772 | CID_10614907 | |
| 0.018 | 0.017 | 0.036 | Kainate receptor 5 antagonist | 0.036 0.008 CID_10614907 | CID_10614907 | |
| 0.014 | 0.014 | 0.015 | CC chemokine 10 receptor antagonist | 0.015 0.012 CID_10614907 | CID_10614907 | |
| 0.081 | 0.081 | 0.118 | Polo-like kinase-1 inhibitor | 0.118 0.031 CID_10614907 | CID_10614907 | |
| 0.063 | 0.062 | 0.073 | Benzodiazepine agonist | 0.073 0.047 CID_10614907 | CID_10614907 | |
| 0.037 | 0.037 | 0.058 | Dopamine D2 agonist | 0.058 0.022 CID_10614907 | CID_10614907 | |
| 0.078 | 0.08 | 0.086 | Hematopoietic | 0.086 0.056 CID_10614907 | CID_10614907 | |
| 0.022 | 0.026 | 0.064 | AMPA 1 receptor antagonist | 0.064 0.009 CID_10614907 | CID_10614907 | |
| 0.032 | 0.036 | 0.035 | Cholecystokinin B agonist | 0.035 0.03 CID_10614907 | CID_10614907 | |
| 0.029 | 0.033 | 0.033 | GHS receptor antagonist | 0.033 0.021 CID_10614907 | CID_10614907 | |
| 0.035 | 0.039 | 0.038 | Melanocortin 4 antagonist | 0.038 0.034 CID_10614907 | CID_10614907 | |
| 0.044 | 0.051 | 0.074 | 5 Hydroxytryptamine 4 antagonist | 0.074 0.015 CID_10614907 | CID_10614907 | |
| 0.036 | 0.043 | 0.045 | Histamine H2 receptor agonist | 0.045 0.027 CID_10614907 | CID_10614907 | |
| 0.039 | 0.046 | 0.044 | Histamine H1 receptor agonist | 0.044 0.03 CID_10614907 | CID_10614907 | |
| 0.068 | 0.075 | 0.157 | Adrenaline agonist | 0.087 0.049 CID_10614907 0.157 0.013 CID_154699772 | CID_154699772 | |
| 0.033 | 0.042 | 0.036 | Nicotinic acid receptor 1 agonist | 0.036 0.035 CID_10614907 | CID_10614907 | |
| 0.069 | 0.08 | 0.131 | MAP-kinase-activated kinase inhibitor | 0.131 0.021 CID_10614907 | CID_10614907 | |
| 0.129 | 0.14 | 0.172 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.172 0.094 CID_10614907 | CID_10614907 | |
| 0.02 | 0.031 | 0.028 | Somatostatin 5 antagonist | 0.028 0.025 CID_154699772 | CID_154699772 | |
| 0.111 | 0.123 | 0.154 | Acetylcholine M1 receptor antagonist | 0.143 0.082 CID_10614907 0.154 0.07 CID_154699772 | CID_154699772 | |
| 0.061 | 0.074 | 0.118 | MAP-kinase-activated kinase 2 inhibitor | 0.118 0.02 CID_10614907 | CID_10614907 | |
| 0.017 | 0.031 | 0.03 | Glutaminyl-peptide cyclotransferase inhibitor | 0.03 0.006 CID_10614907 | CID_10614907 | |
| 0.061 | 0.075 | 0.066 | MDM2 inhibitor | 0.066 0.051 CID_10614907 | CID_10614907 | |
| 0.016 | 0.031 | 0.019 | Follicle-stimulating hormone antagonist | 0.019 0.015 CID_10614907 | CID_10614907 | |
| 0.134 | 0.15 | 0.151 | Death-associated protein kinase 2 inhibitor | 0.151 0.104 CID_10614907 | CID_10614907 | |
| 0.019 | 0.036 | 0.024 | Histamine H3 receptor agonist | 0.024 0.023 CID_10614907 | CID_10614907 | |
| 0.058 | 0.075 | 0.074 | Acetylcholine M4 receptor antagonist | 0.074 0.053 CID_10614907 | CID_10614907 | |
| 0.085 | 0.103 | 0.105 | Nav1.4 sodium channel blocker | 0.105 0.069 CID_154699772 | CID_154699772 | |
| 0.112 | 0.131 | 0.142 | MAP3K9 inhibitor | 0.142 0.073 CID_10614907 0.138 0.079 CID_154699772 | CID_10614907 | |
| 0.025 | 0.045 | 0.084 | 5 Hydroxytryptamine 3B antagonist | 0.084 0.006 CID_10614907 | CID_10614907 | |
| 0.03 | 0.049 | 0.037 | Growth hormone release inhibitor | 0.037 0.035 CID_10614907 | CID_10614907 | |
| 0.155 | 0.175 | 0.249 | MAP-kinase-activated kinase 5 inhibitor | 0.249 0.06 CID_10614907 | CID_10614907 | |
| 0.094 | 0.115 | 0.125 | Toll-Like receptor 2 antagonist | 0.125 0.072 CID_10614907 | CID_10614907 | |
| 0.021 | 0.049 | 0.031 | 5 Hydroxytryptamine 6 agonist | 0.031 0.015 CID_10614907 | CID_10614907 | |
| 0.054 | 0.088 | 0.064 | Prolactin release inhibitor | 0.064 0.036 CID_10614907 | CID_10614907 | |
| 0.038 | 0.071 | 0.119 | 5 Hydroxytryptamine 3 antagonist | 0.119 0.014 CID_10614907 | CID_10614907 | |
| 0.039 | 0.076 | 0.099 | CXC chemokine 4 receptor antagonist | 0.099 0.025 CID_10614907 | CID_10614907 | |
| 0.042 | 0.08 | 0.057 | Adrenaline uptake inhibitor | 0.056 0.049 CID_10614907 0.057 0.048 CID_154699772 | CID_154699772 | |
| 0.062 | 0.101 | 0.078 | GABA B receptor agonist | 0.078 0.046 CID_10614907 | CID_10614907 | |
| 0.055 | 0.096 | 0.08 | Somatostatin 1 agonist | 0.079 0.052 CID_10614907 0.08 0.051 CID_154699772 | CID_154699772 | |
| 0.028 | 0.068 | 0.045 | AMPA 4 receptor antagonist | 0.045 0.019 CID_10614907 | CID_10614907 | |
| 0.022 | 0.063 | 0.051 | Potassium channel (Inward rectifier) 1 blocker | 0.051 0.004 CID_154699772 | CID_154699772 | |
| 0.049 | 0.092 | 0.066 | Interferon inducer | 0.066 0.041 CID_10614907 | CID_10614907 | |
| 0.035 | 0.08 | 0.041 | Heme oxygenase inhibitor | 0.041 0.039 CID_154699772 | CID_154699772 | |
| 0.119 | 0.165 | 0.191 | EphB2 antagonist | 0.163 0.117 CID_10614907 0.191 0.094 CID_154699772 | CID_154699772 | |
| 0.005 | 0.054 | 0.024 | Kainate receptor 1 antagonist | 0.024 0.013 CID_10614907 | CID_10614907 | |
| 0.043 | 0.094 | 0.105 | 5 Hydroxytryptamine 3 agonist | 0.105 0.013 CID_10614907 | CID_10614907 | |
| 0.103 | 0.154 | 0.132 | Growth hormone agonist | 0.132 0.104 CID_10614907 | CID_10614907 | |
| 0.034 | 0.085 | 0.061 | Histamine H4 receptor antagonist | 0.061 0.018 CID_10614907 | CID_10614907 | |
| 0.018 | 0.072 | 0.083 | 5 Hydroxytryptamine 2C agonist | 0.083 0.01 CID_10614907 | CID_10614907 | |
| 0.082 | 0.138 | 0.106 | Acetylcholine release stimulant | 0.106 0.074 CID_10614907 | CID_10614907 | |
| 0.05 | 0.11 | 0.065 | Beta 2 adrenoreceptor agonist | 0.065 0.033 CID_154699772 | CID_154699772 | |
| 0.023 | 0.083 | 0.051 | AMPA receptor antagonist | 0.051 0.03 CID_10614907 | CID_10614907 | |
| 0.038 | 0.105 | 0.097 | Neuronal nicotinic receptor antagonist | 0.097 0.025 CID_10614907 | CID_10614907 | |
| 0.008 | 0.078 | 0.026 | Histamine H4 receptor agonist | 0.026 0.008 CID_10614907 | CID_10614907 | |
| 0.159 | 0.231 | 0.242 | Insulysin inhibitor | 0.242 0.104 CID_10614907 | CID_10614907 | |
| 0.015 | 0.088 | 0.053 | Kainate receptor antagonist | 0.053 0.02 CID_10614907 | CID_10614907 | |
| 0.034 | 0.109 | 0.054 | Carbonic anhydrase stimulant | 0.054 0.048 CID_10614907 | CID_10614907 | |
| 0.049 | 0.131 | 0.075 | Interferon agonist | 0.075 0.06 CID_10614907 | CID_10614907 | |
| 0.044 | 0.13 | 0.072 | Beta 3 adrenoreceptor antagonist | 0.072 0.031 CID_154699772 | CID_154699772 | |
| 0.027 | 0.115 | 0.062 | Protein kinase C theta inhibitor | 0.062 0.033 CID_10614907 | CID_10614907 | |
| 0.029 | 0.12 | 0.05 | Nicotinic receptor alpha4 subunit antagonist | 0.05 0.033 CID_10614907 | CID_10614907 | |
| 0.025 | 0.117 | 0.097 | Toll-Like receptor 8 antagonist | 0.097 0.01 CID_10614907 | CID_10614907 | |
| 0.051 | 0.147 | 0.081 | Pim-1 kinase inhibitor | 0.081 0.08 CID_10614907 | CID_10614907 | |
| 0.077 | 0.175 | 0.111 | Histone deacetylase SIRT1 inhibitor | 0.111 0.103 CID_10614907 | CID_10614907 | |
| 0.017 | 0.117 | 0.032 | Protein kinase C beta II inhibitor | 0.032 0.023 CID_10614907 | CID_10614907 | |
| 0.052 | 0.156 | 0.125 | Prolactin inhibitor | 0.125 0.035 CID_10614907 | CID_10614907 | |
| 0.03 | 0.135 | 0.046 | Beta adrenoreceptor agonist | 0.046 0.029 CID_154699772 | CID_154699772 | |
| 0.077 | 0.187 | 0.106 | Antibacterial (Helicobacter pylori) | 0.106 0.105 CID_10614907 | CID_10614907 | |
| 0.102 | 0.213 | 0.142 | Platelet aggregation inhibitor | 0.142 0.139 CID_10614907 | CID_10614907 | |
| 0.063 | 0.175 | 0.138 | Ribosomal protein S6 kinase inhibitor | 0.138 0.074 CID_10614907 | CID_10614907 | |
| 0.037 | 0.152 | 0.097 | Acetylcholine nicotinic antagonist | 0.097 0.041 CID_10614907 | CID_10614907 | |
| 0.047 | 0.169 | 0.118 | Falcipain 3 inhibitor | 0.118 0.055 CID_10614907 | CID_10614907 | |
| 0.131 | 0.254 | 0.182 | Hypoxia-inducible factor 1 alpha inhibitor | 0.182 0.175 CID_10614907 | CID_10614907 | |
| 0.047 | 0.172 | 0.127 | Protein kinase C delta inhibitor | 0.127 0.033 CID_10614907 | CID_10614907 | |
| 0.038 | 0.165 | 0.084 | Acetylcholine nicotinic agonist | 0.084 0.052 CID_10614907 | CID_10614907 | |
| 0.025 | 0.157 | 0.057 | Alpha 2 adrenoreceptor agonist | 0.057 0.047 CID_10614907 | CID_10614907 | |
| 0.147 | 0.28 | 0.301 | Antiobesity | 0.301 0.115 CID_154699772 | CID_154699772 | |
| 0.194 | 0.329 | 0.288 | Caspase 9 stimulant | 0.288 0.207 CID_10614907 | CID_10614907 | |
| 0.021 | 0.173 | 0.059 | Nicotinic receptor alpha7 subunit antagonist | 0.059 0.03 CID_10614907 | CID_10614907 | |
| 0.02 | 0.178 | 0.053 | Beta 1 adrenoreceptor antagonist | 0.053 0.043 CID_154699772 | CID_154699772 | |
| 0.147 | 0.312 | 0.296 | Calcium channel activator | 0.296 0.096 CID_10614907 0.247 0.151 CID_154699772 | CID_10614907 | |
| 0.049 | 0.22 | 0.152 | Protein kinase C gamma inhibitor | 0.152 0.03 CID_10614907 | CID_10614907 | |
| 0.037 | 0.214 | 0.097 | Polo-like kinase-4 inhibitor | 0.097 0.08 CID_10614907 | CID_10614907 | |
| 0.021 | 0.219 | 0.089 | Protein kinase C beta inhibitor | 0.089 0.02 CID_10614907 | CID_10614907 | |
| 0.036 | 0.236 | 0.091 | DNA intercalator | 0.091 0.085 CID_10614907 | CID_10614907 | |
| 0.127 | 0.339 | 0.356 | GABA C receptor rho-3 antagonist | 0.356 0.082 CID_10614907 | CID_10614907 | |
| 0.111 | 0.323 | 0.425 | Vasodilator, peripheral | 0.382 0.061 CID_10614907 0.425 0.048 CID_154699772 | CID_154699772 | |
| 0.067 | 0.281 | 0.235 | DNA methyltransferase I inhibitor | 0.235 0.053 CID_10614907 | CID_10614907 | |
| 0.101 | 0.342 | 0.13 | Ca2+-transporting ATPase inhibitor | 0.13 0.12 CID_10614907 | CID_10614907 | |
| 0.117 | 0.374 | 0.186 | Tyrosine 3 hydroxylase inhibitor | 0.186 0.162 CID_10614907 | CID_10614907 | |
| 0.075 | 0.337 | 0.151 | Focal adhesion kinase 2 inhibitor | 0.151 0.129 CID_10614907 | CID_10614907 | |
| 0.038 | 0.311 | 0.13 | Cytidine deaminase inhibitor | 0.13 0.091 CID_10614907 | CID_10614907 | |
| 0.057 | 0.334 | 0.163 | Spasmolytic | 0.163 0.151 CID_154699772 | CID_154699772 | |
| 0.029 | 0.311 | 0.106 | Protein kinase C mu inhibitor | 0.106 0.051 CID_10614907 | CID_10614907 | |
| 0.026 | 0.316 | 0.099 | Protein kinase C zeta inhibitor | 0.099 0.052 CID_10614907 | CID_10614907 | |
| 0.076 | 0.377 | 0.236 | Superoxide dismutase inhibitor | 0.236 0.084 CID_10614907 | CID_10614907 | |
| 0.028 | 0.345 | 0.146 | Toll-Like receptor 9 antagonist | 0.146 0.065 CID_10614907 | CID_10614907 | |
| 0.052 | 0.392 | 0.129 | GABA C receptor rho-2 antagonist | 0.129 0.108 CID_10614907 | CID_10614907 | |
| 0.024 | 0.389 | 0.096 | GABA C receptor agonist | 0.096 0.071 CID_10614907 | CID_10614907 | |
| 0.025 | 0.425 | 0.091 | GABA C receptor rho-1 antagonist | 0.091 0.077 CID_10614907 | CID_10614907 | |
| 0.019 | 0.428 | 0.123 | Bronchodilator | 0.123 0.043 CID_154699772 | CID_154699772 | |
| 0.034 | 0.563 | 0.155 | Cyclic AMP phosphodiesterase inhibitor | 0.155 0.144 CID_10614907 | CID_10614907 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |